| Literature DB >> 20012312 |
I C Kiphuth, S Krause, H B Huttner, G Dekomien, T Struffert, R Schröder.
Abstract
Nemaline myopathy (NM) is a genetically and clinically heterogenous muscle disorder, which is myopathologically characterized by nemaline bodies. Mutations in six genes have been reported to cause NM: Nebulin (NEB Pelin 1999), alpha-skeletal muscle actin (ACTA1 Nowak 1999), alpha-slow tropomyosin (TPM3 Laing 1995), beta-tropomyosin (TPM2 Donner 2002), slow troponin T (TNNT1 Johnston 2000) and cofilin 2 (CFL2 Agrawal 2007). The majority of cases are due to mutation in NEB and ACTA1. We report on the clinical, myopathological and muscle MRI findings in a German family with autosomal dominant NM due to a novel pathogenic TPM3 mutation (p.Ala156Thr).Entities:
Mesh:
Substances:
Year: 2009 PMID: 20012312 DOI: 10.1007/s00415-009-5413-y
Source DB: PubMed Journal: J Neurol ISSN: 0340-5354 Impact factor: 4.849